- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 128 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 129 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 132 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 139 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 140 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- September 2024
- 183 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Drug Pipelines
- July 2023
- 30 Pages
United States
From €2503EUR$2,750USD£2,146GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1138EUR$1,250USD£975GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1138EUR$1,250USD£975GBP
- Report
- February 2024
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2024
- 80 Pages
Japan
From €3185EUR$3,500USD£2,731GBP
- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- March 2023
- 130 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- May 2023
- 74 Pages
Global
From €3500EUR$4,120USD£3,106GBP

Lansoprazole is a proton pump inhibitor (PPI) used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and erosive esophagitis. It is also used to reduce the risk of gastric ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Lansoprazole works by reducing the amount of acid produced in the stomach, which helps to relieve symptoms of acid reflux and other gastrointestinal disorders.
Lansoprazole is available in both over-the-counter and prescription forms. Over-the-counter lansoprazole is used to treat frequent heartburn, while prescription lansoprazole is used to treat more serious gastrointestinal disorders. Lansoprazole is available in a variety of formulations, including tablets, capsules, and oral suspensions.
The lansoprazole market is a competitive one, with many companies offering their own formulations of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, AstraZeneca, Takeda Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more